Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $11.75, along with a high estimate of $15.00 and a low estimate of $9.00. This upward ...Ardelyx Inc is a biopharmaceutical company that develops treatments for kidney and gastrointestinal diseases. Find out the latest stock price, quote and news for ARDX on CNBC, the trusted source ...In this KLM 787 Economy Review, I'll discuss what it was like to fly economy from Amsterdam to Vegas. Overall, I found KLM to be quite nice. Increased Offer! Hilton No Annual Fee 7...Track reAlpha Tech Corp. (AIRE) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsADS Crude Carriers News: This is the News-site for the company ADS Crude Carriers on Markets Insider Indices Commodities Currencies StocksArdelyx, Inc. is a biopharmaceutical company, which engages in the research, development and commercialization of medicine for the treatment of renal diseases. It focuses on the formulation of programs directed toward treating gastrointestinal and irritable bowel syndrome with constipations.Ardelyx has a Phase 2 potassium lowering compound, RDX013, for the potential treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease and an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD.Track HeartBeam Inc (BEAT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTo access the live webcast of Ardelyx's session, please visit the Events & Presentations page within the Investor section of the Ardelyx website at ir.ardelyx.com. A replay of the webcast will be ...We Are. Here at Ardelyx®, we are dedicated to improving the lives of patients by discovering, developing and commercializing first-in-class targeted therapies that advance patient care. Using our discovery model, Ardelyx scientists identified new biological mechanisms and pathways that enabled us to develop medicines designed to address ...Sep 8, 2023 · September 8, 2023 - 8:00 am. WALTHAM, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that Mike Raab, president and chief executive officer of Ardelyx, will present at the H.C ...Ardelyx (ARDX) delivered earnings and revenue surprises of 500% and 59.45%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?Ardelyx Inc's stock price closed at $8.820. It is up 101.370% in the last 3 months and up 187.300% in the last 12 months. Ardelyx Inc saw 2 positive EPS revisions and 3 negative EPS revisions in ...Track CorMedix Inc (CRMD) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Phio Pharmaceuticals Corp (PHIO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comTrack Ardelyx Inc (ARDX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.Latest FSRN News. No FSRN news at the moment. Track Fisker Inc (FSRN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like …Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update. Company reports $45.6 million in Q1 product-related revenue, including $28.4 million in net product sales revenue for IBSRELA and $15.2 million in net product sales revenue for XPHOZAH. 19 days ago - GlobeNewsWire.We would like to show you a description here but the site won’t allow us.395 subscribers in the ARDELYX community. The selective sodium hydrogen exchanger 3 (NHE3) inhibitor Tenapanor is being developed by Ardelyx Inc for…Joby Aviation (NYSE: JOBY) stock is up about 8% and trending on social media and financial news websites today.The catalyst for the gains and the attention was the firm's announcement that it ...Laying food flat in a freezer bag is a great way to ensure it freezes evenly and with minimal damage. Getting liquidy foods into a yielding plastic sack, on the other hand, present...A list of the latest Ardelyx Inc News - ARDX Stock News, Press Releases, Earnings Report, Financial Disclosures, Offerings, Acquisitions.Track BioCardia Inc. (BCDA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors395 subscribers in the ARDELYX community. The selective sodium hydrogen exchanger 3 (NHE3) inhibitor Tenapanor is being developed by Ardelyx Inc for…Choice Hotels are squarely in the mid- and lower-tier group of hotel chains. But look closer to find hidden gems. Let's take a Choice Privileges deep dive! Increased Offer! Hilton ...Per-Share Earnings, Actuals and Estimates. View the latest Nkarta Inc. (NKTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.Revenue Per Employee. $595,917.60. Enterprise Value/EBITDA. -27.47. Home. Symbol. ARDX. Fundamentals. Get all financial information for Ardelyx Inc (ARDX) including Market Capitalization, PE Ratio, EBITDA, EPS, previous close and open price, 52 week high & 52 week low, Beta and much more.3 days ago · Rhea-AI Summary. Ardelyx, Inc. (Nasdaq: ARDX) reported $45.6 million in Q1 product-related revenue, with $28.4 million from IBSRELA and $15.2 million from XPHOZAH. The company ended Q1 with around $203 million in cash and investments. Ardelyx saw significant growth in net product sales revenue for both IBSRELA and XPHOZAH, with plans to expand ...View the latest Ardelyx Inc. (ARDX) stock price, news, historical charts, analyst ratings and financial information from WSJ.Track Ardelyx Inc (ARDX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTipRanks | Stock Market Research, News and Analyst Forecasts ...Strong commercial performance of IBSRELA continues, ending FY 2023 with $80.1 million in net product sales revenue; 2024 net product sales revenue currently expected to be between $140.0 to $150.0 million. XPHOZAH launch off to a strong start, ending FY 2023 with $2.5 million in net product sales revenue. Company ends FY 2023 …Track Olaplex Holdings Inc (OLPX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsDiscover Ardelyx Inc (ARDX) market and community sentiment, movement in message volume, participation score and buzz level in the Stocktwits communityDiscover Ardelyx Inc (ARDX) market and community sentiment, movement in message volume, participation score and buzz level in the Stocktwits communityFind the latest Ardelyx, Inc. (ARDX) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock analysis for Ardelyx Inc (ARDX:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Ardelyx stock has received a consensus rating of buy. The average rating score is and is based on 19 buy ratings, 3 hold ratings, and 0 sell ratings. What was the 52-week low for Ardelyx stock?ARDX | Complete Ardelyx Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Our lead candidate tenapanor,. discovered and developed by Ardelyx, is a first-in-class, targeted therapy for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. Tenapanor has a unique mechanism of action and acts locally in the gut to inhibit the sodium/hydrogen exchanger 3 (NHE3). This results in a …"The responder analysis from the PHREEDOM trial, the onset of action analysis from the Phase 3 program, and new data generated from our Phase 4 studies further build on the body of evidence that support the potential role that XPHOZAH, as a first-in-class phosphate absorption inhibitor, could play in the management of …How much Jennifer Lawrence makes per film and endorsement deal. By clicking "TRY IT", I agree to receive newsletters and promotions from Money and its partners. I agree to Money's ...Revenue Per Employee. $595,917.60. Enterprise Value/EBITDA. -27.47. Home. Symbol. ARDX. Fundamentals. Get all financial information for Ardelyx Inc (ARDX) including Market Capitalization, PE Ratio, EBITDA, EPS, previous close and open price, 52 week high & 52 week low, Beta and much more.Laying food flat in a freezer bag is a great way to ensure it freezes evenly and with minimal damage. Getting liquidy foods into a yielding plastic sack, on the other hand, present...Track Ardelyx Inc (ARDX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsConference call scheduled for 4:30 p.m. Eastern Time. WALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced it will hold …WALTHAM, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class ...Track Panbela Therapeutics Inc (PBLA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsGreater Boston 400 Fifth Avenue, Suite 210 Waltham, MA 02451 Bay Area 34175 Ardenwood Boulevard Fremont, CA 94555Nov 18, 2022 · Shares of Ardelyx (ARDX Quick Quote ARDX - Free Report) were up 41% on Nov 17 after management announced thatan FDA Advisory Committee recommended approving the company’s new drug application ...Ardelyx released a business update Monday stating that the company expects its FDA-approved IBS treatment, Ibsrela, to achieve greater than ten percent market share at peak and generate more than ...TipRanks | Stock Market Research, News and Analyst Forecasts ...ARDX Earnings Date and Information. Ardelyx last announced its quarterly earnings data on May 2nd, 2024. The biopharmaceutical company reported ($0.11) EPS for the quarter, beating analysts' consensus estimates of ($0.13) by $0.02. The firm earned $46 million during the quarter, compared to the consensus estimate of $36.40 million.Ardelyx is a well-funded biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. This presentation is intended for investor purposes only and is not intended for promotional purposes.Greater Boston 400 Fifth Avenue, Suite 210 Waltham, MA 02451 Bay Area 34175 Ardenwood Boulevard Fremont, CA 94555Ardelyx, Inc. Reports Employment Inducement Grants. WALTHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that on May 6, …ARDX. Net Product Sales Revenue: IBSRELA generated $80.1 million in 2023, with Q4 showing a 26% increase over Q3. 2024 Revenue Forecast: Ardelyx projects IBSRELA sales to reach between $140.0 to .... The best online master's in education administrView the latest Ardelyx Inc. (ARDX) stock price, news, historic Ardelyx, Inc. Common Stock (ARDX) Stock Price, Quote, News & History | Nasdaq. ARDX has a High Technical Rating by Nasdaq Dorsey Wright. Discover why technical analysis matters. $9.31. +0.16....Billion Dollar Secret. View Ardelyx, Inc ARDX investment & stock information. Get the latest Ardelyx, Inc ARDX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Track Crexendo Inc (CXDO) Stock Price, Quote, latest community 3 days ago · Investors & Media. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Ardelyx’s financial performance into perspective. Volume: Today's Open: Previous Close: Data Provided by Refinitiv. 2007. 267. Mike Raab. www.ardelyx.com. Ardelyx, ...
Continue Reading